QuantiFERON-TB®Gold Plus as a potential tuberculosis treatment monitoring tool.
National Hospital Organization Hokkaido Medical Center, Sapporo, Japan kamada@me.com.
Arisu
A
Kamada
National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.
Masaru
M
Amishima
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D007371:Interferon-gamma; D059425:Interferon-gamma Release Tests; D007564:Japan; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D011446:Prospective Studies; D014374:Tuberculin Test / Q000379:methods; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D007371:Interferon-gamma